AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $110,000 | -91.4% | 17,927 | -86.0% | 0.01% | -76.0% |
| Q2 2019 | $1,282,000 | +504.7% | 128,375 | +678.2% | 0.05% | +316.7% |
| Q1 2019 | $212,000 | +16.5% | 16,497 | +37.5% | 0.01% | +33.3% |
| Q4 2018 | $182,000 | -90.9% | 12,000 | -86.5% | 0.01% | -70.0% |
| Q1 2017 | $1,997,000 | +662.2% | 88,600 | +728.0% | 0.03% | +233.3% |
| Q3 2016 | $262,000 | -48.3% | 10,700 | -50.7% | 0.01% | -64.0% |
| Q1 2016 | $507,000 | -38.0% | 21,700 | -19.9% | 0.02% | -50.0% |
| Q4 2015 | $818,000 | -69.5% | 27,100 | -59.9% | 0.05% | -75.2% |
| Q3 2015 | $2,685,000 | – | 67,600 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
| Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
| Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
| Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
| Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |